SAFETY AND EFFICACY OF N9-GP, A RECOMBINANT GLYCOPEGYLATED FACTOR IX WITH EXTENDED HALF-LIFE, IN US VS GLOBAL PATIENTS WITH HEMOPHILIA B: RESULTS FROM THE PARADIGM (TM) CLINICAL PROGRAM
AMERICAN JOURNAL OF HEMATOLOGY(2018)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要